From Rhetoric to Results in U.S. Healthcare Delivery
How healthcare leaders are funding, delivering, reimbursing and scaling women's health across the United States

Women’s health is no longer a fringe benefits add-on or an isolated clinical specialty -- it is core healthcare infrastructure. Yet, progress remains bottlenecked by conflicting stakeholder timelines, fragmented payment rails, and an acute evidence gap.

Produced in partnership with Foravisét, this cross-sector study investigates the exact friction points preventing scientific innovation from converting into routine clinical and commercial practice. We surveyed operational decision-makers across health plans, health systems, biopharma, employers, and clinical care to uncover how U.S. healthcare leaders are funding, reimbursing, delivering, and scaling women’s health in 2026.